ALK-Abello A/S (AKBLF)
36.14
0.00 (0.00%)
USD |
OTCM |
Dec 10, 16:00
ALK-Abello Market Cap: 8.008B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 223.46B |
| Genmab A/S | 19.88B |
| Ascendis Pharma A/S | 12.82B |
| Evaxion AS | 40.24M |
| IO Biotech, Inc. | 62.12M |
Market Cap Related Metrics
| PE Ratio | 49.01 |
| PS Ratio | 8.894 |
| PEG Ratio | 1.142 |
| Price to Book Value | 8.241 |
| Price to Free Cash Flow | 198.42 |
| Price | 36.14 |
| Earnings Yield | 2.04% |
| PEGY Ratio | 1.142 |
| Operating PE Ratio | 36.63 |
| Normalized PE Ratio | 49.01 |